Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Breast Cancer Screening With Dual-Energy Contrast-Enhanced Spectral Mammography to Digital Breast Tomosynthesis in Women With Dense Breasts (Contrast Mammography Imaging Screening Trial

NCT05625659 is registered in ClinicalTrials.gov with American College of Radiology as lead sponsor.

NCT NCT05625659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05625659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Breast Cancer Screening With Dual-Energy Contrast-Enhanced Spectral Mammography to Digital Breast Tomosynthesis in Women With Dense Breasts (Contrast Mammography Imaging Screening Trial
Lead sponsor
American College of Radiology
Phase
Not applicable
Overall status
Recruiting
Start date
March 24, 2023
Completion date
July 31, 2027
Enrollment
2,032 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer